<VariationArchive RecordType="classified" VariationID="2506272" VariationName="NM_001904.4(CTNNB1):c.1863dup (p.Ala622fs)" VariationType="Duplication" Accession="VCV002506272" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-08-06" DateCreated="2023-06-24" MostRecentSubmission="2023-06-24">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2671228" VariationID="2506272">
      <GeneList>
        <Gene Symbol="CTNNB1" FullName="catenin beta 1" GeneID="1499" HGNC_ID="HGNC:2514" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3p22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="41199505" stop="41240443" display_start="41199505" display_stop="41240443" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="41240941" stop="41281938" display_start="41240941" display_stop="41281938" Strand="+" />
          </Location>
          <OMIM>116806</OMIM>
          <Haploinsufficiency last_evaluated="2017-11-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CTNNB1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2017-11-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CTNNB1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001904.4(CTNNB1):c.1863dup (p.Ala622fs)</Name>
      <CanonicalSPDI>NC_000003.12:41236406:TT:TTT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>3p22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="41236406" stop="41236407" display_start="41236406" display_stop="41236407" variantLength="1" positionVCF="41236406" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="41277897" stop="41277898" display_start="41277897" display_stop="41277898" variantLength="1" positionVCF="41277897" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
      </Location>
      <ProteinChange>A615fs</ProteinChange>
      <ProteinChange>A622fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1108" sequenceAccession="LRG_1108">
            <Expression>LRG_1108:g.41958dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1108t1" sequenceAccession="LRG_1108t1">
            <Expression>LRG_1108t1:c.1863dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1108p1" sequenceAccession="LRG_1108p1" change="p.Ala622fs">
            <Expression>LRG_1108p1:p.Ala622fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.41277899dup" Assembly="GRCh37">
            <Expression>NC_000003.11:g.41277899dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.41236408dup" Assembly="GRCh38">
            <Expression>NC_000003.12:g.41236408dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_013302.2" sequenceAccession="NG_013302" sequenceVersion="2" change="g.41958dup">
            <Expression>NG_013302.2:g.41958dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001098209.2" sequenceAccession="NM_001098209" sequenceVersion="2" change="c.1863dup">
            <Expression>NM_001098209.2:c.1863dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001091679.1" sequenceAccession="NP_001091679" sequenceVersion="1" change="p.Ala622fs">
            <Expression>NP_001091679.1:p.Ala622fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001098210.2" sequenceAccession="NM_001098210" sequenceVersion="2" change="c.1863dup">
            <Expression>NM_001098210.2:c.1863dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001091680.1" sequenceAccession="NP_001091680" sequenceVersion="1" change="p.Ala622fs">
            <Expression>NP_001091680.1:p.Ala622fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001330729.2" sequenceAccession="NM_001330729" sequenceVersion="2" change="c.1842dup">
            <Expression>NM_001330729.2:c.1842dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001317658.1" sequenceAccession="NP_001317658" sequenceVersion="1" change="p.Ala615fs">
            <Expression>NP_001317658.1:p.Ala615fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001904.4" sequenceAccession="NM_001904" sequenceVersion="4" change="c.1863dup" MANESelect="true">
            <Expression>NM_001904.4:c.1863dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001895.1" sequenceAccession="NP_001895" sequenceVersion="1" change="p.Ala622fs">
            <Expression>NP_001895.1:p.Ala622fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001904.4(CTNNB1):c.1863dup (p.Ala622fs) AND Severe intellectual disability-progressive spastic diplegia syndrome" Accession="RCV003236503" Version="1">
        <ClassifiedConditionList TraitSetID="9236">
          <ClassifiedCondition DB="MedGen" ID="C3554449">Severe intellectual disability-progressive spastic diplegia syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-05-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-05-24" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-06-24" MostRecentSubmission="2023-06-24">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="9236" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17594" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS</ElementValue>
                <XRef Type="MIM" ID="615075" DB="OMIM" />
                <XRef Type="Allelic variant" ID="116806.0020" DB="OMIM" />
                <XRef Type="Allelic variant" ID="116806.0023" DB="OMIM" />
                <XRef Type="Allelic variant" ID="116806.0017" DB="OMIM" />
                <XRef Type="Allelic variant" ID="116806.0018" DB="OMIM" />
                <XRef Type="Allelic variant" ID="116806.0021" DB="OMIM" />
                <XRef Type="Allelic variant" ID="116806.0022" DB="OMIM" />
                <XRef Type="Allelic variant" ID="116806.0019" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Severe intellectual disability-progressive spastic diplegia syndrome</ElementValue>
                <XRef ID="MONDO:0014035" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NEDSDV</ElementValue>
                <XRef Type="MIM" ID="615075" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3505" />
                <XRef ID="3505" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">CTNNB1 neurodevelopmental disorder (CTNNB1-NDD) is characterized in all individuals by mild-to-profound cognitive impairment and in up to 39% of reported individuals by exudative vitreoretinopathy, an ophthalmologic finding consistent with familial exudative vitreoretinopathy (FEVR). Other common findings include truncal hypotonia, peripheral spasticity, dystonia, behavior problems, microcephaly, and refractive errors and strabismus. Less common features include intrauterine growth restriction, feeding difficulties, and scoliosis.</Attribute>
                <XRef ID="NBK580527" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">35593792</ID>
                <ID Source="BookShelf">NBK580527</ID>
              </Citation>
              <XRef ID="404473" DB="Orphanet" />
              <XRef ID="C3554449" DB="MedGen" />
              <XRef ID="MONDO:0014035" DB="MONDO" />
              <XRef Type="MIM" ID="615075" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7354352" SubmissionDate="2023-06-21" DateLastUpdated="2023-06-24" DateCreated="2023-06-24">
        <ClinVarSubmissionID localKey="NM_001904.3:c.1863dupT|MedGen:C3554449" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003934805" DateUpdated="2023-06-24" DateCreated="2023-06-24" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Variant summary: CTNNB1 c.1863dupT (p.Ala622CysfsX11) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant was absent in 251066 control chromosomes (gnomAD). To our knowledge, no occurrence of c.1863dupT in individuals affected with Severe Intellectual Disability-Progressive Spastic Diplegia Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. This variant has been observed as a de novo occurrence in an infant internally. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CTNNB1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001904.3:c.1863dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3554449" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13562035</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7354352" TraitType="Disease" MappingType="XRef" MappingValue="C3554449" MappingRef="MedGen">
        <MedGen CUI="C3554449" Name="Severe intellectual disability-progressive spastic diplegia syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

